Aytu BioPharma, Inc. (AYTU) Financials

$2.65

$0.02 (0.76%)
Last update: 04:00 PM EST
Day's range
$2.59
Day's range
$2.69
$150M$150M$100M$100M$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150MEarning201820182019201920202020202120212022202220232023202420240%0%-200%-200%-400%-400%-600%-600%-800%-800%-1000%-1000%-1200%-1200%Profit Margin
Profit Margin
Revenue
Earnings

AYTU Income statement / Annual

Last year (2024), Aytu BioPharma, Inc.'s total revenue was $81.00 M, a decrease of 24.58% from the previous year. In 2024, Aytu BioPharma, Inc.'s net income was -$15.84 M. See Aytu BioPharma, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 06/30/2024 06/30/2023 06/30/2022 06/30/2021 06/30/2020 06/30/2019 06/30/2018 06/30/2017 06/30/2016 06/30/2015
Operating Revenue $81.00 M $107.40 M $96.67 M $65.63 M $27.63 M $7.32 M $3.66 M $3.22 M $2.56 M $261.78 K
Cost of Revenue $26.42 M $40.77 M $44.39 M $36.43 M $7.55 M $2.20 M $2.05 M $1.42 M $957.08 K $88.11 K
Gross Profit $54.59 M $66.63 M $52.28 M $29.20 M $20.08 M $5.12 M $1.61 M $1.80 M $1.61 M $173.67 K
Gross Profit Ratio 0.67 0.62 0.54 0.44 0.73 0.7 0.44 0.56 0.63 0.66
Research and Development Expenses $2.79 M $4.10 M $14.44 M $5.62 M $1.72 M $589.07 K $167.60 K $1.35 M $6.32 M $3.42 M
General & Administrative Expenses $22.51 M $28.63 M $31.17 M $25.50 M $19.66 M $0.00 $17.73 M $17.61 M $8.83 M $4.38 M
Selling & Marketing Expenses $26.96 M $41.45 M $38.71 M $30.31 M $11.40 M $0.00 $0.00 -$242.00 $0.00 $0.00
Selling, General & Administrative Expenses $49.47 M $70.08 M $69.88 M $55.81 M $31.06 M $19.24 M $17.73 M $17.61 M $8.83 M $4.38 M
Other Expenses $7.58 M $9.52 M $4.07 M $6.01 M $4.49 M $2.14 M $6.28 M $1.71 M $664.71 K $4.89 K
Operating Expenses $60.57 M $83.70 M $88.39 M $67.44 M $41.01 M $21.96 M $19.45 M $20.66 M $15.81 M $7.81 M
Cost And Expenses $86.26 M $124.46 M $132.77 M $103.87 M $48.57 M $24.17 M $21.50 M $22.08 M $16.77 M $7.89 M
Interest Income $0.00 $9.00 K $14.00 K $6.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $4.79 M $4.96 M $147.50 M $0.00 $0.00 $0.00 $749.42 K $2.53 M $5.49 M $114.99 K
Depreciation & Amortization $8.27 M $8.82 M $10.15 M $7.70 M $4.59 M $2.24 M $1.85 M $1.84 M $874.79 K $118.20 K
EBITDA -$1.01 M -$3.27 M -$27.96 M -$29.04 M -$12.21 M -$14.12 M -$15.25 M -$18.13 M -$21.81 M -$7.51 M
EBITDA Ratio -0.01 -0.03 -0.29 -0.44 -0.44 -1.93 -4.17 -5.63 -8.51 -28.7
Operating Income Ratio -0.06 -0.16 0.38 -0.58 -0.76 -2.3 -5.38 -6.25 -8.47 -29.16
Total Other Income/Expenses Net -$8.82 M $14.00 K $1.02 M $840.00 K $7.51 M -$10.29 M $9.51 M -$2.38 M -$6.48 M -$114.99 K
Income Before Tax -$14.08 M -$17.05 M -$110.28 M -$58.03 M -$13.62 M -$27.13 M -$10.19 M -$22.51 M -$28.18 M -$7.75 M
Income Before Tax Ratio -0.17 -0.16 -1.14 -0.88 -0.49 -3.71 -2.78 -6.99 -11 -29.59
Income Tax Expense $1.77 M -$57.00 K -$110.00 K $259.00 K -$9.92 M $20.04 M $0.00 $0.00 $0.00 -$23.91 K
Net Income -$15.84 M -$17.05 M -$108.78 M -$58.29 M -$13.62 M -$47.17 M -$10.19 M -$22.51 M -$28.18 M -$7.72 M
Net Income Ratio -0.2 -0.16 -1.13 -0.89 -0.49 -6.44 -2.78 -6.99 -11 -29.5
EPS -2.86 -5.11 -74.01 -69.6 -60.2 -1210.28 -3061.23 -193194.38 -1294738.36 -551671.71
EPS Diluted -2.86 -5.11 -74.01 -69.6 -60.2 -1210.28 -3061.23 -193194.38 -1294738.36 -551671.71
Weighted Average Shares Out $5.54 M $3.34 M $1.47 M $840.00 K $230.00 K $38.97 K $3.33 K $116.51 $21.77 $14.00
Weighted Average Shares Out Diluted $5.54 M $3.34 M $1.47 M $840.00 K $230.00 K $38.97 K $3.33 K $116.51 $21.77 $14.00
Link